Stay updated on Clinical Trial: QLT091001 in Autosomal Dominant RPE65 RP.
Sign up to get notified when there's something new on the Clinical Trial: QLT091001 in Autosomal Dominant RPE65 RP. page.

Latest updates to the Clinical Trial: QLT091001 in Autosomal Dominant RPE65 RP. page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedAdded a Quebec location under Locations and updated the revision to v3.3.3; the older Quebec Locations entry and HHS Disclosure link were removed.SummaryDifference0.3%

- Check27 days agoNo Change Detected
- Check42 days agoChange DetectedFooter revision updated from v3.3.1 to v3.3.2, changing the version label in the page footer.SummaryDifference0.1%

- Check49 days agoChange DetectedThe publication note was updated to indicate PubMed auto-fill and to display Revision: v3.3.1. The previous wording about PubMed publications being automatically created by the NCT identifier was removed.SummaryDifference0.1%

- Check56 days agoChange DetectedRemoval of a site-wide funding/operating-status notice banner; the study details, eligibility criteria, and locations remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check70 days agoChange DetectedThe new screenshot shows minor UI/layout changes to the Study Details page, such as rearranged sections and updated header visuals. There is no evidence of changes to the actual study content, including eligibility criteria, primary or secondary outcomes, or enrollment. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check99 days agoChange DetectedPage now includes an official operating-status notice and updates version to v3.2.0, replacing v3.1.0.SummaryDifference6%

Stay in the know with updates to Clinical Trial: QLT091001 in Autosomal Dominant RPE65 RP.
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: QLT091001 in Autosomal Dominant RPE65 RP. page.